WO2011011808A1 - Composition cosmétique comprenant du chlorure de sodium en combinaison avec et/ou au moins une protéine, un collagène, une gélatine, un acide aminé - Google Patents

Composition cosmétique comprenant du chlorure de sodium en combinaison avec et/ou au moins une protéine, un collagène, une gélatine, un acide aminé Download PDF

Info

Publication number
WO2011011808A1
WO2011011808A1 PCT/AU2009/000963 AU2009000963W WO2011011808A1 WO 2011011808 A1 WO2011011808 A1 WO 2011011808A1 AU 2009000963 W AU2009000963 W AU 2009000963W WO 2011011808 A1 WO2011011808 A1 WO 2011011808A1
Authority
WO
WIPO (PCT)
Prior art keywords
skin
substances
protein
combination
collagen
Prior art date
Application number
PCT/AU2009/000963
Other languages
English (en)
Other versions
WO2011011808A8 (fr
Inventor
Roman Buga
Original Assignee
Roman Buga
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roman Buga filed Critical Roman Buga
Priority to PCT/AU2009/000963 priority Critical patent/WO2011011808A1/fr
Publication of WO2011011808A1 publication Critical patent/WO2011011808A1/fr
Publication of WO2011011808A8 publication Critical patent/WO2011011808A8/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Definitions

  • Protein, Collagen or Gelatin have as naturally glue or binding-agents the best presupposition in this matter; additionally having all 3 substances some Amino acids integrated. Protein, collagen and gelatin bind the water and Salt(sodium chloride) in the best way; this gives us the best result what we need on the skin. We have a combination of water: which gives us the moisturizing and the salt which gives us the nutritionsupply.
  • CO2 it self is useful for the cosmetic surgeon or dermatologist to perform skin resurfacing what reduce or eliminate the pronounced lines and wrinkles and to stimulate the regeneration of a healthy skin underneath.
  • Amino acids essential or non essential have the capability to renew the skin-cells or other cells. It is a accelerator for woundhealing and faster grow of protein. Protein react faster in the grow specially with essential amino acids. Amino acids react fast, but don't can go a long distance in the acceleration.
  • the wound is closing faster as normal.
  • the salt combine with the amino acids and react to CO2, from now on the Protein/collagen/gelatin make a thin mask over the skin and slowing the process of the reaction down.
  • the protein or collagen or gelatin release slowly the amino acids and these is reacting slowly.
  • the Amino acids have a second task, its reacting with the skin and stimulate the growth of the cells in the skin, the gelatin/protein/collagen as mask over it gives the skin a smoother surface and the new
  • the 10 day cycle from 1 treatment the outer skin is smooth, but it get back to his old path after the 10 days; so when you want the new layers or the skin grow in the new path of the smooth outer skin, you need to hold the smooth skin in place for a minimum of 30 days(this is the cycle of the skin-growing-time).
  • the combination of salt its possible to treat scars or other skin-illness, but not open wounds(this can be painful).
  • the wound is open and need to stop the bleeding: the collagen stops with a thin skin over the wound the bleeding and the amino acids starts to stimulate the Protein-cells to stop the bleeding and to grow faster with the cells, so the wound close down faster. It can be any Protein-cell, from the tissue or from the blood.
  • This contraction can be done anywhere on the body. It is so strong you can shape a body with it and hold in position over a couple of days and with a stronger combination of the substances over a longer period up to 2 month with one treatment.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L’invention concerne une composition cosmétique comprenant du chlorure de sodium en combinaison avec et/ou au moins une protéine, un collagène, une gélatine, un acide aminé, et ses utilisations.
PCT/AU2009/000963 2009-07-30 2009-07-30 Composition cosmétique comprenant du chlorure de sodium en combinaison avec et/ou au moins une protéine, un collagène, une gélatine, un acide aminé WO2011011808A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/AU2009/000963 WO2011011808A1 (fr) 2009-07-30 2009-07-30 Composition cosmétique comprenant du chlorure de sodium en combinaison avec et/ou au moins une protéine, un collagène, une gélatine, un acide aminé

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/AU2009/000963 WO2011011808A1 (fr) 2009-07-30 2009-07-30 Composition cosmétique comprenant du chlorure de sodium en combinaison avec et/ou au moins une protéine, un collagène, une gélatine, un acide aminé

Publications (2)

Publication Number Publication Date
WO2011011808A1 true WO2011011808A1 (fr) 2011-02-03
WO2011011808A8 WO2011011808A8 (fr) 2011-07-21

Family

ID=43528620

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/AU2009/000963 WO2011011808A1 (fr) 2009-07-30 2009-07-30 Composition cosmétique comprenant du chlorure de sodium en combinaison avec et/ou au moins une protéine, un collagène, une gélatine, un acide aminé

Country Status (1)

Country Link
WO (1) WO2011011808A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011055800A1 (de) * 2011-11-29 2013-05-29 Gelita Ag Verwendung von Kollagenhydrolysat
EP2785420B1 (fr) * 2011-11-29 2018-03-14 Gelita AG Traitement cosmétique de l'hydrolysat de collagène

Citations (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0385155A2 (fr) * 1989-02-21 1990-09-05 Klein, Peter, Prof.Dr.med. Préparation cosmétique pour le traitement de la peau
WO1999060951A1 (fr) * 1998-05-22 1999-12-02 Isolagen Technologies, Inc. Compositions pour la regeneration de tissu degenere et procedes d'utilisation desdites compositions
WO2000007465A1 (fr) * 1998-08-03 2000-02-17 Toh-Men Co., Ltd. Solution permettant de reanimer des cellules d'organismes multicellulaires et procede de reanimation de cellules d'organismes multicellulaires utilisant celle-ci
WO2000072872A1 (fr) * 1999-06-02 2000-12-07 Human Genome Sciences, Inc. Formulations a base de fecteur de croissance keratinocytaire 2
WO2002000272A2 (fr) * 2000-06-29 2002-01-03 Biosyntech Canada Inc. Composition et procede de reparation et de regeneration de cartilage et d'autres tissus
US20020041903A1 (en) * 1997-09-17 2002-04-11 Eric T. Fossel Topical delivery of arginine of cause beneficial effects
US6432710B1 (en) * 1998-05-22 2002-08-13 Isolagen Technologies, Inc. Compositions for regenerating tissue that has deteriorated, and methods for using such compositions
JP2002308783A (ja) * 2001-04-13 2002-10-23 Geo Co Ltd 皮膚または粘膜疾患予防、治療用医薬組成物
WO2003005979A2 (fr) * 2001-07-07 2003-01-23 Beiersdorf Ag Preparations cosmetiques et dermatologiques contenant des osmolytes destinees au traitement et a la prevention active de la secheresse cutanee et d'autres modifications negatives de l'homeostasie physiologique de la peau saine
US20040265268A1 (en) * 2001-08-18 2004-12-30 Deepak Jain Compositions and methods for skin rejuvenation and repair
WO2005010282A1 (fr) * 2003-07-25 2005-02-03 Bridgest0Ne Corporation Brise-glace et voie navigable equipee d'un brise-glace
FR2864445A1 (fr) * 2003-12-30 2005-07-01 Jean Noel Thorel Utilisation topique d'une base nutritive complexe
WO2005067867A1 (fr) * 2004-01-20 2005-07-28 Kose Corporation Produit cosmetique
US20050277568A1 (en) * 2004-06-14 2005-12-15 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Fibrous elastic gel cleansing article
WO2006015675A1 (fr) * 2004-08-04 2006-02-16 Henkel Kommanditgesellschaft Auf Aktien Preparation cosmetique pour la peau a base de lipides polyinsatures
US20070154424A1 (en) * 2005-01-19 2007-07-05 Kose Corporation Cosmetic
WO2008082525A1 (fr) * 2006-12-19 2008-07-10 National Stem Cell Inc Compositions topiques dérivées de substances sécrétées par les cellules souches du cordon ombilical et leurs méthodes d'utilisation
WO2009016629A2 (fr) * 2007-07-30 2009-02-05 Healor Ltd. Composition pharmaceutique et procédés apparentés
US20090105336A1 (en) * 2004-04-19 2009-04-23 Strategic Science & Technologies, Llc Beneficial Effects of Increasing Local Blood Flow
US20090131537A1 (en) * 2007-11-14 2009-05-21 Wille Jr John Jacob Wound healing compositions

Patent Citations (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0385155A2 (fr) * 1989-02-21 1990-09-05 Klein, Peter, Prof.Dr.med. Préparation cosmétique pour le traitement de la peau
US20020041903A1 (en) * 1997-09-17 2002-04-11 Eric T. Fossel Topical delivery of arginine of cause beneficial effects
WO1999060951A1 (fr) * 1998-05-22 1999-12-02 Isolagen Technologies, Inc. Compositions pour la regeneration de tissu degenere et procedes d'utilisation desdites compositions
US6432710B1 (en) * 1998-05-22 2002-08-13 Isolagen Technologies, Inc. Compositions for regenerating tissue that has deteriorated, and methods for using such compositions
WO2000007465A1 (fr) * 1998-08-03 2000-02-17 Toh-Men Co., Ltd. Solution permettant de reanimer des cellules d'organismes multicellulaires et procede de reanimation de cellules d'organismes multicellulaires utilisant celle-ci
WO2000072872A1 (fr) * 1999-06-02 2000-12-07 Human Genome Sciences, Inc. Formulations a base de fecteur de croissance keratinocytaire 2
WO2002000272A2 (fr) * 2000-06-29 2002-01-03 Biosyntech Canada Inc. Composition et procede de reparation et de regeneration de cartilage et d'autres tissus
JP2002308783A (ja) * 2001-04-13 2002-10-23 Geo Co Ltd 皮膚または粘膜疾患予防、治療用医薬組成物
WO2003005979A2 (fr) * 2001-07-07 2003-01-23 Beiersdorf Ag Preparations cosmetiques et dermatologiques contenant des osmolytes destinees au traitement et a la prevention active de la secheresse cutanee et d'autres modifications negatives de l'homeostasie physiologique de la peau saine
US20040265268A1 (en) * 2001-08-18 2004-12-30 Deepak Jain Compositions and methods for skin rejuvenation and repair
WO2005010282A1 (fr) * 2003-07-25 2005-02-03 Bridgest0Ne Corporation Brise-glace et voie navigable equipee d'un brise-glace
FR2864445A1 (fr) * 2003-12-30 2005-07-01 Jean Noel Thorel Utilisation topique d'une base nutritive complexe
WO2005067867A1 (fr) * 2004-01-20 2005-07-28 Kose Corporation Produit cosmetique
US20090105336A1 (en) * 2004-04-19 2009-04-23 Strategic Science & Technologies, Llc Beneficial Effects of Increasing Local Blood Flow
US20050277568A1 (en) * 2004-06-14 2005-12-15 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Fibrous elastic gel cleansing article
WO2006015675A1 (fr) * 2004-08-04 2006-02-16 Henkel Kommanditgesellschaft Auf Aktien Preparation cosmetique pour la peau a base de lipides polyinsatures
US20070154424A1 (en) * 2005-01-19 2007-07-05 Kose Corporation Cosmetic
WO2008082525A1 (fr) * 2006-12-19 2008-07-10 National Stem Cell Inc Compositions topiques dérivées de substances sécrétées par les cellules souches du cordon ombilical et leurs méthodes d'utilisation
WO2009016629A2 (fr) * 2007-07-30 2009-02-05 Healor Ltd. Composition pharmaceutique et procédés apparentés
US20090131537A1 (en) * 2007-11-14 2009-05-21 Wille Jr John Jacob Wound healing compositions

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011055800A1 (de) * 2011-11-29 2013-05-29 Gelita Ag Verwendung von Kollagenhydrolysat
EP2785420B1 (fr) * 2011-11-29 2018-03-14 Gelita AG Traitement cosmétique de l'hydrolysat de collagène

Also Published As

Publication number Publication date
WO2011011808A8 (fr) 2011-07-21

Similar Documents

Publication Publication Date Title
Haslik et al. First experiences with the collagen-elastin matrix Matriderm® as a dermal substitute in severe burn injuries of the hand
Clark et al. Superficial and medium-depth chemical peels
ES2421142T3 (es) Administración tópica de un donante de óxido nítrico para mejorar el aspecto corporal y de la piel
US8372130B2 (en) Temperature controlled facial mask with area-specific treatments
JP2649531B2 (ja) 化粧学的活性物質と結合した有機シリコン化合物からなる生成物
CN101878019A (zh) 含有具有基序gx1x2g、px1x2p或者px1x2k的四肽的个人护理和化妆品组合物
Manchester Tattoo removal—a new simple technique
CN104921983A (zh) 一种孕妇妊娠纹医用生物修复敷料及其制备方法
CN102133168B (zh) 一种美容面膜及其制备方法
CA2797707C (fr) Systeme et procede visant a rendre les cicatrices et tissus cicatriciels moins apparents
CA3085867A1 (fr) Coussinet en silicone comprenant des principes actifs pour les soins de la peau et contre le vieillissement de la peau
WO2011011808A1 (fr) Composition cosmétique comprenant du chlorure de sodium en combinaison avec et/ou au moins une protéine, un collagène, une gélatine, un acide aminé
CN107029219B (zh) 一种促进皮肤组织再生的药膏
US20060293227A1 (en) Cosmetic compositions and methods using transforming growth factor-beta mimics
JP4036295B2 (ja) 人体に塗布、付着させる組成物
CN1895216A (zh) 珍珠护肤面贴膜及其制备方法
JP2004534076A (ja) 傷の治療および再上皮形成のための糖蛋白質の使用
CN105853252B (zh) 一种用于皮肤热损伤的温敏水凝胶及其制备方法
KR20070117311A (ko) 세안이 불필요한 원적외선 미용팩
WO2015051260A2 (fr) Composition pour les soins de la peau contenant une substance biologique
DeHaven Copper Tripeptide-1
RU2252016C1 (ru) Способ оздоровления кожи, чувствительной к стрессовым факторам
Łubkowska et al. The use of synthetic polypeptides in cosmetics
CN110200840A (zh) 一种具有抑菌、修复再生、补水保湿、延缓衰老作用的复合生物酶组合物
EP3790568A1 (fr) Surnageant de culture de microalgues enrichi en imac et ses utilisations

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09847678

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09847678

Country of ref document: EP

Kind code of ref document: A1